Biotechnology has emerged as a driving force in transforming healthcare. Over the past few decades, the integration of biology with advanced technology has led to significant breakthroughs. These ...

Lower rates make more funding available, which helps biotech companies expand, draw in venture capital ... and precision medicine transform how we treat uncommon genetic illnesses, autoimmune ...

Gilead Sciences is drawing up $20 million cash to partner ... and earn more near-term preclinical milestones as well. The biotech is also eligible to receive an undisclosed amount of development ...

Cambridge, MA – March 5, 2025 – Today, Insilico Medicine, a clinical-stage biotechnology company pioneering generative AI for drug discovery and development, announced the deployment of the ...

Fluorescent dyes are tools used throughout biotechnology and medicine that offer a unique method of detecting and quantifying the presence of a target molecule, cell, or tissue within an even more ...